Arax Advisory Partners’s NeoGenomics NEO Stock Holding History

Arax Advisory Partners’s Portfolio NEO Stock Details NEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$123K	Buy	+8,402	New	+$81.1K	﹤0.01%	2587
2026 Q1	–	Sell	-54	Closed	-$635	–	4156
2025 Q4	$635	Buy	+54	New	+$583	﹤0.01%	3567
2025 Q3	–	Sell	-35	Closed	-$256	–	4068
2025 Q2	$256	Buy	+35	New	+$282	﹤0.01%	2972
2024 Q4	–	Sell	-59	Closed	-$871	–	2631
2024 Q3	$871	Hold	59	–	–	﹤0.01%	2296
2024 Q2	$819	Buy	+59	New	+$836	﹤0.01%	2229

Other funds holding NEO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Greenhouse Funds Baltimore, Maryland $1.96B AUM 36.47% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

Arax Advisory Partners's NEO Position: Q2 2026 in Review

Arax Advisory Partners opened a new position in NeoGenomics (NEO) in Q2 2026: 8,402 shares worth $123K. The stake represents ﹤0.01% of the portfolio and ranks #2587 among its holdings. This is a return to the name: Arax Advisory Partners previously reported a position in NEO as recently as Q4 2025.

Arax Advisory Partners first reported a position in NEO in Q2 2024 and has held it in 5 quarters since. 266 funds tracked by Wall St. Rank hold NEO as of Q2 2026.

Arax Advisory Partners held 8,402 shares of NeoGenomics worth $123K as of Q2 2026.
NeoGenomics was a new Arax Advisory Partners position in Q2 2026.
NeoGenomics made up ﹤0.01% of Arax Advisory Partners's portfolio in Q2 2026, its #2587 holding.
Arax Advisory Partners first reported a position in NeoGenomics in Q2 2024 and has held it in 5 quarters since.
266 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2026.

Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.